Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Risk of prostate cancer in patients with schizophrenia
Gil Raviv
,
Menachem Laufer
, Yehuda Baruch
, Yoram Barak
*
*
Corresponding author for this work
Clinical Departments
Surgery
Sheba Medical Center at Tel Hashomer
Abarbanel Mental Health Center
Tel Aviv University
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Risk of prostate cancer in patients with schizophrenia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Patients with Schizophrenia
100%
Prostate Cancer
100%
Cancer Inpatients
100%
Schizophrenic Patients
50%
Schizophrenia
50%
Standardized Incidence Ratio
50%
Lung Cancer
33%
Hyperprolactinemia
16%
Antipsychotics
16%
Risk Reduction
16%
Expected Rate
16%
Relative Risk
16%
Sex Hormones
16%
Patients Included
16%
National Cancer Registry
16%
Tertiary Care
16%
Mental Hospital
16%
Reduced Rate
16%
Conflicting Evidence
16%
Organ System
16%
Medicine and Dentistry
Prostate Cancer
100%
Lung Cancer
33%
Malignant Neoplasm
16%
Cancer Registry
16%
Mental Health
16%
Tertiary Care
16%
Sex Hormone
16%
Organ Systems
16%
Hyperprolactinemia
16%
Antipsychotic Drug
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Lung Cancer
33%
Malignant Neoplasm
16%
Hyperprolactinemia
16%
Sex Hormone
16%
Cancer Registry
16%
Antipsychotic Drug
16%